Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDC14B | O60729 | 9/20 | 0.44 |
| ▸ | CDC14A | Q9UNH5 | 9/20 | 0.44 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | MAOA | P21397 | 2/20 | 0.35 |
| ▸ | EPM2A | O95278 | 1/20 | 0.33 |
| ▸ | PTPRC | P08575 | 1/20 | 0.33 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.33 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.33 |
| ▸ | ACP1 | P24666 | 1/20 | 0.33 |
| ▸ | PTPN6 | P29350 | 1/20 | 0.33 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.33 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.33 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.33 |
| ▸ | PTPN13 | Q12923 | 1/20 | 0.33 |
| ▸ | DUSP23 | Q9BVJ7 | 1/20 | 0.33 |
| ▸ | PTPN22 | Q9Y2R2 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21343396 | 0.89 | CDC14B (0.44) | CDC14BCDC14AALOX5MEN1KMT2A | |
| SCHEMBL4554342 | 0.80 | ALOX5 (0.54) | CDC14BCDC14AALOX5MEN1KMT2A | |
| SCHEMBL24862831 | 0.79 | CDC14B (0.40) | CDC14BCDC14AALOX5MEN1KMT2A | |
| SCHEMBL21343381 | 0.79 | CDC14B (0.48) | CDC14BCDC14AALOX5MEN1KMT2A | |
| SCHEMBL22376432 | 0.79 | ALOX5 (0.44) | CDC14BCDC14AALOX5MEN1KMT2A | |
| SCHEMBL19585040 | 0.79 | ALOX5 (0.55) | CDC14BCDC14AALOX5CYP19A1 | |
| SCHEMBL18311678 | 0.77 | SLC22A12 (0.41) | MEN1KMT2ACYP2C19CYP3A4MAPT | |
| SCHEMBL25853300 | 0.76 | CDC14B (0.43) | CDC14BCDC14AALOX5MAOAKDM4E | |
| SCHEMBL24936797 | 0.76 | HTR6 (0.30) | — | |
| SCHEMBL18926702 | 0.76 | CDC14B (0.43) | CDC14BCDC14AALOX5MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230232650-A1 | ORGANOELECTROLUMINESCENT DEVICE USING POLYCYCLIC AROMATIC COMPOUNDS | SFC CO., LTD (KR) | 2023-07-20 | — | — | US | disclosed |
| US-20230232650-A1 | ORGANOELECTROLUMINESCENT DEVICE USING POLYCYCLIC AROMATIC COMPOUNDS | SFC CO., LTD (KR) | 2023-07-20 | — | — | US | disclosed |
| US-20230134334-A1 | AMINE COMPOUND HAVING FUSED RING, AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | SFC CO., LTD (KR) | 2023-05-04 | — | — | US | disclosed |
| US-20230134334-A1 | AMINE COMPOUND HAVING FUSED RING, AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | SFC CO., LTD (KR) | 2023-05-04 | — | — | US | disclosed |
| EP-4123737-A1 | ORGANOELECTROLUMINESCENT DEVICE USING POLYCYCLIC AROMATIC COMPOUNDS | SFC Co., Ltd. (KR) | 2023-01-25 | — | — | EP | disclosed |
| EP-4119554-A1 | AMINE COMPOUND HAVING FUSED RING, AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | SFC Co., Ltd. (KR) | 2023-01-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230134334-A1 | AMINE COMPOUND HAVING FUSED RING, AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | EML4, SLC18A2, TYR | CDC14B 3208/4885CDC14A 3551/4885ALOX5 1770/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.